Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_assertion description "[CFCS is genetically heterogeneous and mutations in the KRAS, BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2) genes, encoding for components of the RAS-mitogen activated protein kinase (MAPK) signaling pathway, have been identified in up to 90% of cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_assertion evidence source_evidence_literature NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_assertion SIO_000772 19156172 NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_assertion wasDerivedFrom befree-20150227 NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_assertion wasGeneratedBy ECO_0000203 NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.
- befree-20150227 importedOn "2015-02-27" NP528052.RA0-ybK6Zba3q63PNbkwY4nhWp6GCxx-Ndf_riUSqLf50130_provenance.